Hello MSWorld Members,

Welcome to our new home! We hope you love it as much as we do!

we promise.

to offer current and relevant information.

to grow a community built on positive and affirming support.

to showcase member creativity.

to provide safe chat rooms.

to provide well moderated forums.

we believe that what we give as a community comes back to us.

welcome to MSWorld on this journey through a different lens. together. we are msworld.
we are. community.

We appreciate your understanding as we finalize our new home. Our arcade is still currently under construction and wont be available for a while. Thank you for your patience while we prepare a new and improved arcade for you.

enjoy our new home.

support reimagined.
See more
See less

Third FDA-Approved Therapy for NMO

  • Filter
  • Time
  • Show
Clear All
new posts

    Third FDA-Approved Therapy for NMO

    FDA Approves Treatment for Rare Disease Affecting Optic Nerves, Spinal Cord

    Third FDA-Approved Therapy in Just Over a Year for Neuromyelitis Optica Spectrum Disorder Gives Patients Another Treatment Option

    Until last year, there were no FDA-approved treatments for patients with this rare, debilitating and sometimes fatal disease. Now there are three, said Billy Dunn, M.D., director of the Office of Neuroscience in the FDAs Center for Drug Evaluation and Research. Todays approval of Enspryng highlights the FDAs commitment to rapidly advancing safe and effective therapies for NMOSD and other neurological diseases.
    PPMS for 22 years (dx 1998)
    ~ Worrying will not take away tomorrow's troubles ~ But it will take away today's peace. ~